#GuillainBarre

Health & Fitness | Coronavirus Resources

Guillain-Barré syndrome: FDA warns of potential rare neurological complication with Johnson & Johnson coronavirus vaccine

The US Food and Drug Administration updated the label on Johnson & Johnson's coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome.